1[1]Klaus MH,Fanaroff AA.Care of the high risk neonate.4th ed.Philadelphia:Saunders Co,1993:118 被引量：1
2[2]Short MA.A comparison of temperature in VLBW infants swaddled versus unswaddled in a double-walled incubator in skin control mode.Neonatal-Netw,1998;17(13):25 被引量：1
3[3]Vaidya UV,Bhave SA,Pandit AN.Parenteral nutrition in the management of very low birth weight(VLBW) babies:a randomized controlled trial.Indian Pediatr,1995;32(2):165 被引量：1
5Bhatia J. Current option in the management of apnea of prematurity [J]. Clin Pediatr. 2000, 39(6) :327-336. 被引量：1
6Lee TC, Charles B, Steer P, et al. Population pharmacokinetics of intravenous caffeine in apnea of prematurity [J]. Clin Pharmacol Ther, 1997, 61:628-640. 被引量：1
7Erenberg A, Leff R, Wynne B, et al. Results of the first double-blind placebo-controlled study of caffeine citrate for the treatment of apnea of prematurity(AOP) [J]. Pediatr. 1998, 102:756-757. 被引量：1
8Comer AM, Perry CM, Figgitt DP. Caffeine citrate: a review of its use in apnea of prematurity [J]. Paediatr Drugs. 2001, 3(1):61-79. 被引量：1
9Poets CF, Darraj S, Bohnhorst B. Effect of doxapram on episodes of apnea, bradycardia and hypoxaemia in preterm infants. Biol Neonate 1999, 76:207-213. 被引量：1
10Sreenan C, Lemke RP, Hudson-Mason A, et al. High-flow nasal cannulae in the management of apnea of prematurity:a comparison with conventional nasal continuous positive airway pressure[J]. Pediatr. 2001, 107(5) :1081-1083. 被引量：1
